Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Other Accumulated Expenses (2019 - 2026)

Updated

Aligos Therapeutics' Other Accumulated Expenses came in at $4.13 million for Q3 2026, down 14.4% from $4.83 million a year earlier and down 41.2% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025, Aligos Therapeutics' Other Accumulated Expenses was $3.25 million, down 39.6% from FY2024.

  • Other Accumulated Expenses carries a five-year compound annual growth rate of 81.1% (FY2020 to FY2025).
  • Going back by year, Other Accumulated Expenses was $5.38 million in FY2024 (-18.9%), $6.63 million in FY2023 (+350.3%), $1.47 million in FY2022 (+19.3%) and $1.24 million in FY2021 (+639.5%).
  • The five-year range for quarterly Other Accumulated Expenses is $856,000 (Q2 2022) to $7.03 million (Q2 2026).
  • Year-over-year, Other Accumulated Expenses increased in five of the last eight quarters, with growth averaging 21.8%.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in Q4 2021 (growth of 639.5%), and the weakest in Q4 2025 (a decline of 39.6%).
  • Business Quant data shows ALGS's Other Accumulated Expenses at $7.03 million (Q2 2026), $4.26 million (Q1 2026) and $3.25 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.13 Mn
Jun 30, 2026 7.03 Mn
Mar 31, 2026 4.26 Mn
Dec 31, 2025 3.25 Mn
Sep 30, 2025 4.83 Mn
Jun 30, 2025 3.82 Mn
Mar 31, 2025 3.85 Mn
Dec 31, 2024 5.38 Mn
Sep 30, 2024 2.75 Mn
Jun 30, 2024 2.71 Mn
Mar 31, 2024 2.84 Mn
Dec 31, 2023 6.63 Mn
Sep 30, 2023 1.26 Mn
Jun 30, 2023 1.44 Mn
Mar 31, 2023 2.27 Mn
Dec 31, 2022 1.47 Mn
Sep 30, 2022 912,000.00
Jun 30, 2022 856,000.00
Mar 31, 2022 1.14 Mn
Dec 31, 2021 1.24 Mn
API Access

Aligos Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ALGS&period=max&api_key=YOUR_API_KEY